Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.8% |
| 2 | Healthcare | 9.1% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Badger Meter
BMI
$3.89B
| $34.3M | 0.01% |
545,891
-106,130
| -16% | -$6.3M |
|
1252
Wolfspeed
WOLF
$1.23B
| $34.3M | 0.01% |
579,325
+287,894
| +99% | +$13.9M |
|
1253
Popular Inc
BPOP
$11.2B
| $34.3M | 0.01% |
921,602
-564,680
| -38% | -$21M |
|
1254
Axsome Therapeutics
AXSM
$11.2B
| $34.2M | 0.01% |
416,210
+196,203
| +89% | +$15.1M |
|
1255
Alkermes
ALKS
$8.22B
| $34.1M | 0.01% |
1,758,313
+267,571
| +18% | +$4.34M |
|
1256
AB InBev
BUD
$170B
| $34.1M | 0.01% |
691,536
+163,691
| +31% | +$7.65M |
|
1257
Rogers Corp
ROG
$2.21B
| $34.1M | 0.01% |
273,521
+156,715
| +134% | +$16.8M |
|
|
CMD
1258
DELISTED
Cantel Medical Corporation
CMD
| $34M | 0.01% |
769,609
+466,236
| +154% | +$17.4M |
|
1259
Thor Industries
THO
$3.9B
| $34M | 0.01% |
319,311
-33,079
| -9% | -$2.59M |
|
1260
Raymond James Financial
RJF
$33.8B
| $34M | 0.01% |
740,567
-303,994
| -29% | -$13.7M |
|
|
ABMD
1261
DELISTED
Abiomed Inc
ABMD
| $33.9M | 0.01% |
140,404
-15,681
| -10% | -$3.15M |
|
1262
Advance Auto Parts
AAP
$3.35B
| $33.9M | 0.01% |
237,837
+4,254
| +2% | +$541K |
|
1263
PG&E
PCG
$38.3B
| $33.8M | 0.01% |
3,813,913
+3,329,780
| +688% | +$36.3M |
|
1264
Americold
COLD
$4.02B
| $33.8M | 0.01% |
931,672
-375
| -0% | -$12.8K |
|
|
SAGE
1265
DELISTED
Sage Therapeutics
SAGE
| $33.8M | 0.01% |
812,785
+67,197
| +9% | +$2.44M |
|
1266
Carlyle Group
CG
$16.6B
| $33.8M | 0.01% |
1,210,868
+89,195
| +8% | +$2.29M |
|
1267
Acadia Realty Trust
AKR
$3.09B
| $33.8M | 0.01% |
2,602,002
-307,507
| -11% | -$3.83M |
|
1268
PUT
Etsy
ETSY
$7.75B
| $33.7M | 0.01% |
316,800
+100
| +0% | +$7.4K |
|
1269
Healthcare Realty
HR
$7.28B
| $33.6M | 0.01% |
1,267,207
+269,126
| +27% | +$6.89M |
|
1270
Columbus McKinnon
CMCO
$553M
| $33.6M | 0.01% |
1,003,351
-49,411
| -5% | -$1.36M |
|
1271
Brixmor Property Group
BRX
$9.67B
| $33.5M | 0.01% |
2,613,787
+745,086
| +40% | +$8.42M |
|
1272
PUT
Boeing
BA
$171B
| $33.5M | 0.01% |
182,600
-98,800
| -35% | -$15.2M |
|
|
UMPQ
1273
DELISTED
Umpqua Holdings Corp
UMPQ
| $33.5M | 0.01% |
3,144,709
+1,224,527
| +64% | +$13.7M |
|
1274
Virtu Financial
VIRT
$5.11B
| $33.4M | 0.01% |
1,415,304
-484,708
| -26% | -$11.3M |
|
1275
Rapid7
RPD
$645M
| $33.4M | 0.01% |
653,916
+96,259
| +17% | +$4.48M |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.